fda warning letters compounded semaglutide september 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility FDA Warns 30 Telehealth Companies

Survodutides liver health benefits may translate to improved metabolic flexibility over time

The current supply deficit of Wegovy has led practitioners to start prescribing Ozempic off-label (non-FDA approved use)

Both agents provided clinically meaningful reductions in HbA 1c (2.6 mmol/mol [0.2%] with SGLT2i and 5.4 mmol/mol [0.5%] with GLP-1 RA)

doi: 10.1016/j.carbpol.2020.116942

Visual and physical inspection of a reconstituted peptide solution before each use is a fundamental safety step

Our specialist team reviews your current medications during the eligibility assessment to ensure that combining these treatments is safe and appropriate for your specific biological profile